CD8A and neoplasm: Further, liothyronine could significantly augment the frequency of tumor infiltrating CD8+ T cells, and significantly enhanced the secretion of IFN-γ by tumor infiltrating CD8+ T cells treated with high dose of liothyronine (Fig. 6b, c).